|
Volume 2 Number 2 |
November 1996 |
|
Ribavirin in the treatment of respiratory syncytial virus infections |
36-37 |
||
|
Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure |
38 |
||
|
Acceptance of isoniazid preventive therapy by doctors, medical students and nurses |
39 |
||
|
Acute lung abscess in the third world |
40 |
||
|
Occupational exposure in patients with cryptogenic fibrosing alveolitis |
41 |
||
|
Smoking cessation: should nicotine substitution be modulated by the level of nicotine-dependence? |
42 |
||
|
In smoking cessation: does the combined use of nicotine patch and gum improve the success rates? |
43 |
||
|
How can the (pulmonary) physician help his patients in their smoking cessation attempts? |
44-45 |
||
|
Frequency and degree of exposure to environmental tobacco smoke (passive smoking) |
46 |
||
|
Bronchitis and asthma in female smokers |
47 |
||
|
Surfactant replacement in acute respiratory distress syndrome: does it work? |
48 |
||
|
Post-intubation tracheal stenosis |
49 |
||
|
Spiral volumetric computed tomographic scanning in the assessment of pulmonary embolism |
50 |
||
|
Cost-effectiveness of pulmonary embolism diagnosis |
51 |
||
|
The search for the best method to evaluate chest tumour response to chemotherapy |
52 |
||
|
ANCAs in the pulmonary renal syndrome |
53 |
||
|
Increased mortality in patients with congestive heart failure and periodic breathing during sleep |
54 |
||
|
Nocturia as a symptom of occult sleep disorder |
55 |
||
|
Pertussis in adults |
56 |
||
|
Diagnosing chronic productive cough |
57 |
||
|
Bronchiectasis: an orphan disease? |
58 |
||
|
The effect of inhaled corticosteroids on lung function in patients with cystic fibrosis |
59 |
||
|
Mortality and markers of death in asthma |
60 |
||
|
Decrease in hospitalization for childhood asthma with increased anti-inflammatory treatment |
61 |
||
|
Pulmonary sarcoidosis: to observe or to treat with oral corticosteroids? |
62-63 |
||
|
Tidal breathing analysis as a measure of airway obstruction in children three years of age and older |
64 |
||